Heart Test Laboratories, Inc. (HSCS)
HSCS Stock Price Chart
Explore Heart Test Laboratories, Inc. interactive price chart. Choose custom timeframes to analyze HSCS price movements and trends.
HSCS Company Profile
Discover essential business fundamentals and corporate details for Heart Test Laboratories, Inc. (HSCS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Jun 2022
Employees
15.00
Website
https://heartsciences.comCEO
Andrew Simpson
Description
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
HSCS Financial Timeline
Browse a chronological timeline of Heart Test Laboratories, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 11 Sept 2025
Earnings released on 24 Jul 2025
EPS came in at -$1.88 surpassing the estimated -$2.51 by +25.10%, while revenue for the quarter reached $4.35K .
Earnings released on 13 Mar 2025
EPS came in at -$2.57 falling short of the estimated -$2.53 by -1.58%.
Earnings released on 16 Dec 2024
EPS came in at -$2.27 surpassing the estimated -$2.30 by +1.30%.
Earnings released on 12 Sept 2024
EPS came in at -$2.64 falling short of the estimated -$2.46 by -7.32%.
Earnings released on 29 Jul 2024
EPS came in at -$18.81 falling short of the estimated -$3.50 by -437.43%.
Stock split effective on 17 May 2024
Shares were split 1 : 100 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Mar 2024
EPS came in at -$3.00 falling short of the estimated -$0.06 by -4.90K%, while revenue for the quarter reached $14.70K .
Earnings released on 14 Dec 2023
EPS came in at -$16.00 falling short of the estimated -$0.12 by -13.23K%, while revenue for the quarter reached $3.90K .
Earnings released on 14 Sept 2023
EPS came in at -$13.00 falling short of the estimated -$0.14 by -9.19K%.
Earnings released on 18 Jul 2023
EPS came in at -$16.00 falling short of the estimated -$0.16 by -9.90K%, while revenue for the quarter reached $5.14M .
Earnings released on 16 Mar 2023
EPS came in at -$16.00 falling short of the estimated -$0.16 by -9.90K%, while revenue for the quarter reached $1.95K , beating expectations by +95.00%.
Earnings released on 15 Dec 2022
EPS came in at -$22.00 falling short of the estimated -$0.33 by -6.57K%.
Earnings released on 12 Sept 2022
EPS came in at -$0.28 surpassing the estimated -$28.00 by +99.00%, while revenue for the quarter reached $3.20K , beating expectations by +6.67%.
Earnings released on 29 Jul 2022
EPS came in at -$64.03 , while revenue for the quarter reached $4.15K .
Earnings released on 31 Jan 2022
EPS came in at -$37.27 , while revenue for the quarter reached $2.74K .
Earnings released on 31 Oct 2021
EPS came in at -$31.23 .
Earnings released on 31 Jul 2021
EPS came in at -$15.14 , while revenue for the quarter reached $7.48K .
Earnings released on 30 Apr 2021
EPS came in at -$25.70 , while revenue for the quarter reached $14.95K .
HSCS Stock Performance
Access detailed HSCS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.